Archive: 26/03/2021
Mutations in CTC may predict outcomes in some castrate-resistant prostate cancer patients
Various genetic alterations in circulating tumor cells (CTCs) were associated with clinical outcomes and resistance to hormone therapy in patients with metastatic castrate-resistant prostate cancer (mCRPC), according to results ...
Mar 26, 2021